This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Ablynx N.v.. Active years: 2018-2026.
Company Filing History:
Years Active: 2018-2026
Title: Innovations of Hans Ulrichts in Immunoglobulin Formulations
Introduction
Hans Ulrichts is a notable inventor based in Kortrijk, Belgium. He has made significant contributions to the field of immunology through his innovative work on stable formulations of immunoglobulin single variable domains. His research focuses on enhancing the stability and usability of these formulations for pharmaceutical applications.
Latest Patents
Ulrichts holds a patent for "Stable formulations of immunoglobulin single variable domains." This invention relates to stable formulations of polypeptides, particularly immunoglobulin single variable domains directed against von Willebrand Factor (vWF). The formulations developed by Ulrichts ensure high stability during storage over prolonged periods and across a broad range of temperatures. They allow for multiple freeze-thaw cycles without chemical or physical deterioration, making them suitable for pharmaceutical and diagnostic preparations.
Career Highlights
Hans Ulrichts has been instrumental in advancing the field of immunology through his innovative research. His work has led to the development of formulations that are compatible with pharmaceutically acceptable diluents, ensuring their practical application in the medical field. He is associated with Ablynx N.V., a company known for its focus on therapeutic proteins.
Collaborations
Some of his notable coworkers include Veronique De Brabandere and Filip Callewaert. Their collaboration has contributed to the success of various projects within the company.
Conclusion
Hans Ulrichts continues to be a key figure in the development of stable immunoglobulin formulations, showcasing the importance of innovation in the pharmaceutical industry. His contributions are paving the way for advancements in therapeutic applications.